Latest News and Press Releases
Want to stay updated on the latest news?
- 
                            
MicrobiotiX gains IND approval to initiate clinical trials for its pneumonia therapy designed to combat antibiotic-resistant superbugs.
 - 
                            
MicrobiotiX raises KRW 20B Series B and wins grant to launch Korea’s first phage therapy trial, advancing fight against superbugs.